Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features

Clinical Nuclear Medicine

Volumn 39, Issue 2, 2014, Pages

  Soussan, Michael ^a,b,c   Augier, Alexandre ^b,c   Brillet, Pierre Yves ^a,b,c   Weinmann, Pierre ^a,b,c   Valeyre, Dominique ^a,b,c  

^a UNIVERSITÉ PARIS 13   (France)

^b Avicenne's Teaching Hospital   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

extrathoracic sarcoidosis; FDG PET CT; MR; sarcoidosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMEN; BONE; BONE MARROW; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; EXTRAPULMONARY SARCOIDOSIS; GASTROINTESTINAL TRACT; GRANULOMATOSIS; GRANULOMATOUS INFLAMMATION; HEART; HUMAN; LARYNX; LIVER; LYMPHADENOPATHY; LYMPHOMA; METASTASIS; MUSCULOSKELETAL SYSTEM; PAROTID GLAND; PROGNOSIS; REVIEW; SARCOIDOSIS; SKELETAL MUSCLE; SKIN; SPLEEN; TUBERCULOSIS; UROLOGIC SURGERY;

FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84892963865     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318279f264     Document Type: Review

References (76)

1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357: 2153-2165
2. Koyama T, Ueda H, Togashi K, et al. Radiologic manifestations of sarcoidosis in various organs. Radiographics. 2004;24:87-104
3. Nunes H, Brillet PY, Valeyre D, et al. Imaging in sarcoidosis. Semin Respir Crit Care Med. 2007;28:102-120
4. Prabhakar HB, Rabinowitz CB, Gibbons FK, et al. Imaging features of sarcoidosis on MDCT, FDG PET, and PET/CT. AJR Am J Roentgenol. 2008; 190:S1YS6
5. Treglia G, Taralli S, Giordano A. Emerging role of whole-body 18Ffluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: A systematic review. Sarcoidosis Vasc Diffuse Lung Dis. 2011;28:87-94
6. Braun JJ, Kessler R, Constantinesco A, et al. 18F-FDG PET/CT in sarcoidosis management: Review and report of 20 cases. Eur J Nucl Med Mol Imaging. 2008;35:1537-1543
7. Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med. 2006;47:1571-1576
8. Gotthardt M, Bleeker-Rovers CP, Boerman OC, et al. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med. 2010;51:1937-1949
9. Teirstein AS, Machac J, Almeida O, et al. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest. 2007;132:1949-1953
10. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58:1204-1211
11. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885-1889
12. Nunes H, Freynet O, Naggara N, et al. Cardiac sarcoidosis. Semin Respir Crit Care Med. 2010;31:428-441
13. Ishihara M, Ohara K, Usui M, et al.Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis and Granulomatous Disorders [in Japanese]. 2007;27:89-102
14. Vignaux O. Cardiac sarcoidosis: Spectrum of MRI features. AJR Am J Roentgenol. 2005;184:249-254
15. Deux JF, Maatouk M, Lim P, et al. Acute myocarditis: Diagnostic value of contrast-enhanced cine steady-state free precession MRI sequences. AJR Am J Roentgenol. 2011;197:1081-1087
16. Ichinose A, Otani H, Oikawa M, et al. MRI of cardiac sarcoidosis: Basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am J Roentgenol. 2008;191:862-869
17. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969-1977
18. Ohira H, Tsujino I, Yoshinaga K. (18)F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2011; 38:1773-1783
19. Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med. 2004;45:1989-1998
20. Ohira H, Tsujino I, Ishimaru S, et al. Myocardial imaging with 18F-fluoro-2- deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2008;35:933-941
21. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: Signs, course and treatment in 35 confirmed cases. Medicine (Baltimore). 1990;69:261-276
22. Mirfakhraee M, Crofford MJ, Guinto FC Jr, et al. Virchow-Robin space: A path of spread in neurosarcoidosis. Radiology. 1986;158:715-720
23. Sherman JL, Stern BJ. Sarcoidosis of the CNS: Comparison of unenhanced and enhanced MR images. AJR Am J Roentgenol. 1990;155:1293-1301
24. Lexa FJ, Grossman RI. MR of sarcoidosis in the head and spine: Spectrum of manifestations and radiographic response to steroid therapy. AJNR Am J Neuroradiol. 1994;15:973-982
25. Christoforidis GA, Spickler EM, Recio MV, et al. MR of CNS sarcoidosis: Correlation of imaging features to clinical symptoms and response to treatment. AJNR Am J Neuroradiol. 1999;20:655-669
26. Shah R, Roberson GH, Cure JK. Correlation of MR imaging findings and clinical manifestations in neurosarcoidosis. AJNR Am J Neuroradiol. 2009; 30:953-961
27. RanouxD, DevauxB, Lamy C, et al.Meningeal sarcoidosis, pseudo-meningioma, and pachymeningitis of the convexity. J Neurol Neurosurg Psychiatry. 1992; 55:300-303
28. Wilson JD, Castillo M, Van Tassel P. MRI features of intracranial sarcoidosis mimicking meningiomas. Clin Imaging. 1994;18:184-188
29. Dumas JL, Valeyre D, Chapelon-Abric C, et al. Central nervous system sarcoidosis: Follow-up at MR imaging during steroid therapy. Radiology. 2000; 214:411-420
30. Sauter MK, Panitch HS, Kristt DA. Myelopathic neurosarcoidosis: Diagnostic value of enhanced MRI. Neurology. 1991;41:150-151
31. Scott TF, Yandora K, Valeri A, et al. Aggressive therapy for neurosarcoidosis: Long-term follow-up of 48 treated patients. Arch Neurol. 2007;64:691-696
32. Ota K, Tsunemi T, Saito K, et al. 18F-FDG PET successfully detects spinal cord sarcoidosis. J Neurol. 2009;256:1943-1946
33. Sakushima K, Yabe I, Shiga T, et al. FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis. J Neurol. 2011;258: 227-230
34. Aide N, Benayoun M, Kerrou K, et al. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: Unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy. Br J Radiol. 2007;80:e67Ye71
35. Smith JA, Foster CS. Sarcoidosis and its ocular manifestations. Int Ophthalmol Clin. 1996;36:109-125
36. Demirci H, Christianson MD. Orbital and adnexal involvement in sarcoidosis: Analysis of clinical features and systemic disease in 30 cases. Am J Ophthalmol. 2011;151:1074-1080
37. Zeitlin JF, Tami TA, Baughman R, et al. Nasal and sinus manifestations of sarcoidosis. Am J Rhinol. 2000;14:157-161
38. Wilson R, Lund V, Sweatman M, et al. Upper respiratory tract involvement in sarcoidosis and its management. Eur Respir J. 1988;1:269-272
39. Braun JJ, Gentine A, Pauli G. Sinonasal sarcoidosis: Review and report of fifteen cases. Laryngoscope. 2004;114:1960-1963
40. Bourjat P, Braun J. Sinonasal sarcoidosis: CT evaluation. J Radiol. 2002;83: 467-471
41. Aubart FC, Ouayoun M, Brauner M, et al. Sinonasal involvement in sarcoidosis: A case-control study of 20 patients. Medicine (Baltimore). 2006;85: 365-371
42. Braun JJ, Imperiale A, Riehm S, et al. Imaging in sinonasal sarcoidosis: CT, MRI, 67Gallium scintigraphy and 18F-FDG PET/CT features. J Neuroradiol. 2010;37:172-181
43. Kurdziel KA. The panda sign. Radiology. 2000;215:884-885
44. Oksuz MO, Werner MK, Aschoff P, et al. 18F-FDG PET/CT for the diagnosis of sarcoidosis in a patient with bilateral inflammatory involvement of the parotid and lacrimal glands (panda sign) and bilateral hilar and mediastinal lymphadenopathy (lambda sign). Eur J Nucl Med Mol Imaging. 2011; 38:603
45. Butler CR, Nouraei SA, Mace AD, et al. Endoscopic airway management of laryngeal sarcoidosis. Arch Otolaryngol Head Neck Surg. 2010;136:251-255
46. Warshauer DM, Dumbleton SA, Molina PL, et al. Abdominal CT findings in sarcoidosis: Radiologic and clinical correlation. Radiology. 1994;192:93-98
47. Tombazzi C, Waters B, Ismail MK, et al. Sarcoidosis mimicking primary sclerosing cholangitis requiring liver transplantation. Ann Hepatol. 2008;7: 83-86
48. Warshauer DM, Molina PL, Hamman SM, et al. Nodular sarcoidosis of the liver and spleen: Analysis of 32 cases. Radiology. 1995;195:757-762
49. Warshauer DM, Semelka RC, Ascher SM. Nodular sarcoidosis of the liver and spleen: Appearance on MR images. J Magn Reson Imaging. 1994;4:553-557
50. Love C, Tomas MB, Tronco GG, et al. FDG PET of infection and inflammation. Radiographics. 2005;25:1357-1368
51. Liang DB, Price JC, Ahmed H, et al. Gastric sarcoidosis: Case report and literature review. J Natl Med Assoc. 2010;102:348-351
52. Gontier E, Fourme E, Wartski M, et al. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging. 2008;35:95-99
53. Chandler MB, Zeddun SM, Borum ML. The role of positron emission tomography in the evaluation of inflammatory bowel disease. Ann N Y Acad Sci. 2011;1228:59-63
54. Berliner AR, Haas M, Choi MJ. Sarcoidosis: The nephrologist's perspective. Am J Kidney Dis. 2006;48:856-870
55. Heldmann M, Behm W, Reddy MP, et al. Pseudotumoral renal sarcoid: MRI, PET, and MDCT appearance with pathologic correlation. AJR Am J Roentgenol. 2005;185:697-699
56. Woodward PJ, Sohaey R, O'Donoghue MJ, et al. From the archives of the AFIP: Tumors and tumorlike lesions of the testis: Radiologic-pathologic correlation. Radiographics. 2002;22:189-216
57. James DG, Neville E, Carstairs LS. Bone and joint sarcoidosis. Semin Arthritis Rheum. 1976;6:53-81
58. Moore SL, Teirstein AE. Musculoskeletal sarcoidosis: Spectrum of appearances at MR imaging. Radiographics. 2003;23:1389-1399
59. Mostard RL, Prompers L, Weijers RE, et al. F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med. 2012;37:21-25
60. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35-45
61. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants. Radiographics. 1999;19:61-77; quiz 150-1
62. Otake S, Ishigaki T. Muscular sarcoidosis. Semin Musculoskelet Radiol. 2001;5:167-170
63. Matsuo M, Ehara S, Tamakawa Y, et al. Muscular sarcoidosis. Skeletal Radiol. 1995;24:535-537
64. Tohme-Noun C, Le Breton C, Sobotka A, et al. Imaging findings in three cases of the nodular type of muscular sarcoidosis. AJR Am J Roentgenol. 2004; 183:995-999
65. Otake S, Banno T, Ohba S, et al. Muscular sarcoidosis: Findings at MR imaging. Radiology. 1990;176:145-148
66. Otake S, Imagumbai N, Suzuki M, et al. MR imaging of muscular sarcoidosis after steroid therapy. Eur Radiol. 1998;8:1651-1653
67. Fayad F, Duet M, Orcel P, et al. Systemic sarcoidosis: The ''leopard-man'' sign. Joint Bone Spine. 2006;73:109-112
68. Kolilekas L, Triantafillidou C, Manali E, et al. The many faces of sarcoidosis: Asymptomatic muscle mass mimicking giant-cell tumor. Rheumatol Int. 2009;29:1389-1390
69. Fraioli P, Montemurro L, Castrignano L, et al. Retroperitoneal involvement in sarcoidosis. Sarcoidosis. 1990;7:101-105
70. Warshauer DM, Lee JK. Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol. 2004;182:15-28
71. Aragon-Ching JB, Akin EA. Positron emission tomography findings in clinical mimics of lymphoma. Ann N Y Acad Sci. 2011;1228:19-28
72. Soussan M, Brillet PY, Mekinian A, et al. Patterns of pulmonary tuberculosis on FDG-PET/CT. Eur J Radiol. 2012;81:2872-2876
73. Stokkel MP, van der Hiel B, Olmos RV, et al. Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma. Eur J Nucl Med Mol Imaging. 2012;39:919-920
74. Keijsers RG, Verzijlbergen FJ, Oyen WJ, et al. 18F-FDG PET, genotypecorrected ACE and sIL-2R in newly diagnosed sarcoidosis. Eur J Nucl Med Mol Imaging. 2009;36:1131-1137
75. Keijsers RG, Grutters JC, van Velzen-Blad H, et al. (18)F-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis. Eur J Nucl Med Mol Imaging. 2010;37:1181-1188
76. Berrington de Gonzalez A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009;169:2071-2077